Publication | Closed Access

Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole

NanomedicineMedicinal ChemistryAntifungal AgentSilver Nanoparticle ConjugationMedicineAntibiotic AdjuvantAmphotericin BAntiacanthamoebic ActivitiesAntibacterial AgentAntimicrobial ChemotherapyAntimicrobial CompoundPharmacologyDrug DiscoveryDrug Resistance